2020 AOAC INTERNATIONAL Midyear Meeting
March 9-13, 2020
Gaithersburg Marriott Washingtonian Center

Vape devices create vapor made of fine and ultrafine particles of particulate matter, which have been found to contain propylene glycol, glycerin, nicotine, flavors, small amounts of toxicants, carcinogens, and heavy metals, as well as metal nanoparticles, and other substances.  The exact composition of this varies across and within manufacturers, and depends on the contents of the liquid, the physical and electrical design of the device, and user behavior, among other factors. 

Despite their ever-growing acceptance, relatively little work has been done to characterize the vapor from vape device related to the liquid or the cartridges employed. To date, the majority of the research on the vapor or the devices themselves has focused on characterizing the solutions, which are ultimately vaporized for the end user to inhale.  This townhall will provide a forum to discuss the analytical science of testing vape devices with an eye towards AOAC’s potential role in vaping testing.


Welcome and Introductory Remarks

Scott Coates
Sr. Director, AOAC Research Institute

Discussion Leaders   

TOPIC 1:  Massachusetts Contract Laboratory Prospective

Christopher Hudalla
CSO, ProVerde Labs

TOPIC 2: Canadian Contract Laboratory Prospective

Rob O’brien
CSO and CEO, Supra RnD Laboratories

TOPIC 3: US Federal Government Perspective

Cathy Dasenbrock
Director, Inorganic Branch, Forensic Chemistry Center, U.S. Food and Drug Administration

TOPIC 4: Canadian Federal Government Perspective

Andrew Waye
Controlled Substances and Cannabis Branch, Health Canada